Monitoring of molecular profiling of allergen-antibody responses in HDM-immunotherapy patients

References

• Dhami S, Nurmatov U, Arasi S, Khan T, Asaria M, Zaman H, Agarwal A, Netuveli G, Roberts G, Pfaar O, et al. Allergen immunotherapy for allergic rhinoconjunctivitis: a systematic review and meta-analysis. Allergy. 2017;72(11):1597–8.
   PubMed Web of Science ®Google Scholar
• Farraia M, Paciência I, Castro Mendes F, Cavaleiro Rufo J, Shamji M, Agache I, Moreira A. Allergen immunotherapy for asthma prevention: a systematic review and meta-analysis of randomized and non-randomized controlled studies. Allergy. 2022;77:1719–35.
   PubMed Web of Science ®Google Scholar
• Shamji MH, Kappen JH, Akdis M, Jensen-Jarolim E, Knol EF, Kleine-Tebbe J, Bohle B, Chaker AM, Till SJ, Valenta R, et al. Biomarkers for monitoring clinical efficacy of allergen immunotherapy for allergic rhinoconjunctivitis and allergic asthma: an EAACI position paper. Allergy. 2017;72:1156–73.
   PubMed Web of Science ®Google Scholar
• Roberts G, Pfaar O, Akdis CA, Pfaar OEA, Ansotegui IJ, Durham SR, Gerth van Wijk R, Halken S, Larenas-Linnemann D, Pawankar R, et al. EAACI guidelines on allergen immunotherapy. Allergic Rhinoconjunctivitis Allergy. 2018;73:765–98.
   PubMed Web of Science ®Google Scholar
• Pfaar O, Bousquet J, Durham SR, Jörg Kleine-Tebbe J, Larché M, Roberts G, Shamji MH, Gerth van Wijk R. One hundred and ten years of allergen immunotherapy: a journey from empiric observation to evidence. Allergy. 2021;77:454–68.
   PubMed Web of Science ®Google Scholar
• Agache I, Lau S, Akdis CA, Smolinska S, Bonini M, Cavkaytar O, Flood B, Gajdanowicz P, Izuhara K, Kalayci O, et al. EAACI guidelines on allergen immunotherapy: house dust mite- driven allergic asthma. Allergy. 2019;74:855–73.
   PubMed Web of Science ®Google Scholar
• Bousquet J, Khaltaev N, Cruz AA, Denburg J, Fokkens WJ, Togias A, Zuberbier T, Baena-Cagnani CE, Canonica GW, Van Weel C, et al. Allergic rhinitis and its impact on asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy. 2008;63:8–160.
   PubMed Web of Science ®Google Scholar
• Thomas WR, Hales BJ, Smith WA. House dust mite allergens in asthma and allergy. Trends Mol Med. 2010;16:321–28.
   PubMed Web of Science ®Google Scholar
• WHO/IUIS Allergen Nomenclature Sub-Committee. Allergen nomenclature; [accessed 2021 Oct 1]. http://www.allergen.org.
   Google Scholar
• King TP, Hoffman D, Lowenstein H, Marsh DG, Platts-Mills TA, Thomas W. Allergen nomenclature. Allergy. 1995;50:765–74.
   PubMed Web of Science ®Google Scholar
• Weghofer M, Thomas WR, Kronqvist M, Mari A, Purohit A, Pauli G, Horak F, Grönlund H, van Hage M, Valenta R, et al. Variability of IgE reactivity profiles among European mite allergic patients. Eur J Clin Invest. 2008;38(12):959–65.
   PubMed Web of Science ®Google Scholar
• Zhao L, Zhang Y, Zhang S, Zhang L, Lan F. The effect of immunotherapy on cross-reactivity between house dust mite and other allergens in house dust mite -sensitized patients with allergic rhinitis. Expert Rev Clin Immunol. 2021 Sep;17(9):969–75.
   PubMed Web of Science ®Google Scholar
• Baron-Bodo V, Batard T, Nguyen H, Fréreux M, Horiot S, Harwanegg C, Bergmann KC, de Beaumont O, Moingeon P. Absence of IgE neosensitization in house dust mite allergic patients following sublingual immunotherapy. Clin Exp Allergy. 2012;42:1510–18.
   PubMed Web of Science ®Google Scholar
• Potapova E, Bordas- Le Floch V, Vrtala T, Huang S, Canonica H-J, Valenta GW, Matricardi R, Mascarell PM, Schlederer L. Molecular reactivity profiling upon immunotherapy with a 300 IR sublingual house dust mite tablet reveals marked humoral changes towards major allergens. Allergy. 2022;10:1–12.
   Google Scholar
• Chen KW, Zieglmayer P, Zieglmayer R, Lemell P, Horak F, Bunu CP, Valenta R, Vrtala S. Selection of house dust mite-allergic patients by molecular diagnosis may enhance success of specific immunotherapy. J Allergy Clin Immunol. 2019;143:e1212.
   Web of Science ®Google Scholar
• Rodríguez-Domínguez A, Berings M, Rohrbach A, Huang H-J, Curin M, Gevaert P, Matricardi PM, Valenta R, Vrtala S. Molecular profiling of allergen-specific antibody responses may enhance success of specific immunotherapy. J Allergy Clin Immunol. 2020;146:1097–108.
   PubMed Web of Science ®Google Scholar
• The 2022 update of the Global Strategy for Asthma Management and Prevention; 2022. [ accessed 2022 Jul]. www.ginasthma.org/gina-reports/.
   Google Scholar
• Lupinek C, Marth K, Niederberger V, Valenta R. Analysis of serum IgE reactivity profiles with microarrayed allergens indicates absence of de novo IgE sensitizations in adults. J Allergy Clin Immunol. 2012;130:1418–20 e1414.
   PubMed Web of Science ®Google Scholar
• Gellrich D, Eder K, Högerle C, Becker S, Canis M, Gröger M. De Novo sensitization during subcutaneous allergen specific immunotherapy - an analysis of 51 cases of SCIT and 33 symptomatically treated controls. Sci Rep. 2020;10:5048.
   PubMed Web of Science ®Google Scholar
• Sturm GJ, Varga EM, Roberts G, Becker S, Canis M, Gröger M. EAACI guidelines on allergen immunotherapy: hymenoptera venom allergy. Allergy. 2018 Apr;73(4):744–64.
   PubMed Web of Science ®Google Scholar
• Casset A, Mari A, Purohit A, Resch Y, Weghofer M, Ferrara R, Thomas WR, Alessandri C, Chen K-W, de Blay F, et al. Varying allergen composition and content affects the in vivo allergenic activity of commercial Dermatophagoides pteronyssinus extracts. Int Arch Allergy Immunol. 2012;159:253–62.
   PubMed Web of Science ®Google Scholar
• Caraballo L, Valenta R, Acevedo N, Zakzuk J. Are the terms major and minor allergens useful for precision allergology? Front Immunol. 2021;12:651500.
   PubMed Web of Science ®Google Scholar
• Niederberger, V, Neubauer, A, Gevaert, P, Zidarn, M, Worm, M, and Aberer, M. 2018. Safety and efficacy of immunotherapy with the recombinant B cell epitope-based grass pollen vaccine, BM32. J Allergy Clin Immunol. 142: 497–509.
   PubMed Web of Science ®Google Scholar